Beyond the Smoke Stacks: Texas Ropes in $4 Billion Pharma-Bio Investment
Beyond the Smoke Stacks: Texas Ropes in $4 Billion Pharma-Bio Investment
Attachment: Top 10 Pharma-Biotech Projects in Texas
SUGAR LAND--January 17, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--When many people hear the word "Texas," it evokes a number of clichés, typically a mélange of cattle, chemical plants, oil and gas drilling, and rodeos. But that sells the state short, for beyond the smoke stacks of the hundreds of the state's chemical processing plants and refineries are a surprising number of life-science manufacturing plants and research centers.
Within this article: Details on some of the highest-valued projects in the Texas Pharmaceutical & Biotech Industry, including those from major companies such as Johnson & Johnson (NYSE:JNJ), Allergan plc (NYSE:AGN), Lonza Group and Novartis (NYSE:NVS).
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- 'Ark-La-Tex' Life Science Market Off to a Robust Start With $3.1 Billion In...
- Texas Ropes in More Than $4 Billion in Pharmaceutical-Biotech Capital Inves...
- From Bootscootin' to Biotech: Lone Star Life Science Investment Tops $1.6 B...
- Bioscience Incubators Attract Big Pharma as Bristol-Myers Squibb Offers Sta...
- Texas Ropes in Nearly $4 billion in Pharma-Bio Capital Investment